PROS1 and lung carcinoma: Besides these systemic/nosocomial factors, there is a growing speculation that overexpression of SARS‐CoV‐2 cellular entry proteins might contribute to amplify the risk of viral attachment in lung cancer lesions (Kong et al., 2020).